marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-08-2024
ANI Pharmaceuticals General and Administrative Expenses 2011-2024 | ANIP
Annual General and Administrative Expenses ANI Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 162 M | 124 M | 84.3 M | 65 M | 55.8 M | 44.1 M | 31.6 M | 27.8 M | 21.2 M | 17.9 M | 16.4 M | 8.23 M | 6.98 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 162 M | 6.98 M | 51.2 M |
Quarterly General and Administrative Expenses ANI Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 79.1 M | 52.8 M | 42 M | 38.8 M | 36.5 M | - | 30.1 M | 32 M | 28.8 M | - | 17.2 M | 18.8 M | 17.6 M | - | 15.7 M | 21.2 M | 13.7 M | - | 14.4 M | 14.2 M | 13.3 M | - | 11.8 M | 9.96 M | 8.96 M | - | 8.02 M | 7.38 M | 7.29 M | - | 6.93 M | 7.63 M | 5.9 M | - | 5.4 M | 5.55 M | 4.75 M | - | 4.06 M | 5.43 M | 3.7 M | - | 3.48 M | 7.17 M | 1.95 M | 2.9 M | 1.55 M | 1.95 M | 1.83 M | 1.72 M | 1.68 M | 1.99 M | 1.59 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 79.1 M | 1.55 M | 14.3 M |